FindMyKOL
Clinical trialNCT03283319CompletedPhase 2Interventional

Panblok H7 Vaccine Adjuvanted With AS03 or MF59

SponsorBiomedical Advanced Research and Development AuthorityEnrollment366Influenza, Human
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The main purpose of this study is to assess the safety and ability of a Panblok H7 influenza vaccine adjuvanted with AS03 or MF59 to generate an immune response after 2 doses separated by 28 days. Three different antigen dose levels of Panblok H7 will be tested.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Johnson County Clin-Trials

    Lenexa, Kansas, United States

  • Heartland Research Associates, Llc

    Wichita, Kansas, United States

  • Central Kentucky Research Associates, Inc.

    Lexington, Kentucky, United States

  • Rochester Clinical Research, Inc

    Rochester, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

15 ug Panblok H73.75 ug Panblok H77.5 ug Panblok H7AS03MF59
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
20 Sept 2017
Primary completion
15 Dec 2017
Completion
9 Nov 2018
Last update posted
6 May 2020
Registered enrollment
366
Registry id
NCT03283319

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.